Fennec Pharmaceuticals Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
FENC Company Description
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
FENC Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view FENC Smart Score
Score Breakdown
FENC Company Description
Show More
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of FENC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FENC's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on FENC's company Twitter account
WallStreetBets
Number of mentions of FENC in WallStreetBets Daily Discussion
FENC News
Recent insights relating to FENC
CNBC Recommendations
Recent picks made for FENC stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in FENC
Corporate Flights
Flights by private jets registered to FENC
Our Analysis